Foldyna, Borek http://orcid.org/0000-0002-2466-4827
Zeleznik, Roman
Eslami, Parastou
Mayrhofer, Thomas
Scholtz, Jan-Erik
Ferencik, Maros
Bittner, Daniel O.
Meyersohn, Nandini M.
Puchner, Stefan B.
Emami, Hamed
Pellikka, Patricia A.
Aerts, Hugo J. W. L.
Douglas, Pamela S.
Lu, Michael T.
Hoffmann, Udo
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL098237, R01HL098236, R01HL098305, R01HL098235, U01HL092040, U01HL092022)
American Heart Association (18UNPG34030172, 13FTF16450001)
Office of AIDS Research (5P30AI060354-14)
Article History
Received: 13 October 2020
Revised: 4 December 2020
Accepted: 18 January 2021
First Online: 26 January 2021
Compliance with ethical standards
:
: The scientific guarantor of this publication is Dr. Borek Foldyna.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors (Prof. Thomas Mayrhofer) has significant statistical expertise and no complex statistical methods were necessary for this paper.
: Local and central institutional review boards approved the study, and all patients provided written informed consent.
: Local and central institutional review boards approved the study.
: This investigation is a sub-study of the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial.
: • Secondary analysis• Multicenter randomized controlled trial